Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/1/21 → … |
Funding
- American Society of Clinical Oncology
ASJC Scopus Subject Areas
- Medicine(all)
A phase II trial of sitravatinib, a multireceptor tyrosine kinase inhibitor, in patients with advanced well-differentiated/dedifferentiated liposarcoma
- Oza, Jay (PI)
Project: Research project